Eric Débiton
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 6
- Organic Chemistry top 5%
- Click Chemistry and Applications 5
- Synthesis and biological activity 4
- Pharmacology top 5%
- Pharmacology top 5%
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 9
- Synthesis and bioactivity of alkaloids 4
- DNA Repair Mechanisms 3
- Phytochemical compounds biological activities 3
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Chantal BarthomeufJean‐Claude MadelmontJean LegaultJeroen A.D.M. de RoosWalter M.A. WesterinkW.G.E.J. SchoonenPascale MoreauFabrice Anizon
- Journals
- European Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry (4 papers)Planta Medica (3 papers)
- Partner nations
- FranceCanadaNetherlands
In The Last Decade
Eric Débiton
51 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Toxicology 83
- Organic Chemistry 555
- Pharmacology 144
- Pharmacology 213
- Molecular Biology 855
Countries citing papers authored by Eric Débiton
This map shows the geographic impact of Eric Débiton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Débiton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Débiton more than expected).
Fields of papers citing papers by Eric Débiton
This network shows the impact of papers produced by Eric Débiton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Débiton. The network helps show where Eric Débiton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Débiton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2019 | 14 | |
| 3 | 2017 | 3 | |
| 4 | 2013 | 63 | |
| 5 | 2011 | 18 | |
| 6 | 2009 | 69 | |
| 7 | 2009 | 21 | |
| 8 | 2008 | 48 | |
| 9 | 2008 | 23 | |
| 10 | 2007 | 17 | |
| 11 | 2006 | 48 | |
| 12 | 2006 | 39 | |
| 13 | 2005 | 99 | |
| 14 | 2005 | 55 | |
| 15 | 2004 | 14 | |
| 16 | 2003 | 161 | |
| 17 | 2003 | 105 | |
| 18 | 2002 | 66 | |
| 19 | 2002 | 3 | |
| 20 | 1998 | 6 |
About Eric Débiton
Eric Débiton is a scholar working on Toxicology, Cancer Research, Biotechnology, Biochemistry and Molecular Biology, having authored 51 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (6 papers), Click Chemistry and Applications (5 papers), Synthesis and biological activity (4 papers), Synthesis and bioactivity of alkaloids (4 papers), DNA Repair Mechanisms (3 papers), Phytochemical compounds biological activities (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Toxicology (83 citations), Organic Chemistry (555 citations), Pharmacology (144 citations), Pharmacology (213 citations) and Molecular Biology (855 citations). Eric Débiton has collaborated with scholars based in France, Canada and Netherlands. Frequent co-authors include Chantal Barthomeuf, Jean‐Claude Madelmont, Jean Legault, Jeroen A.D.M. de Roos, Walter M.A. Westerink, W.G.E.J. Schoonen, Pascale Moreau, Fabrice Anizon, André Pichette and Michelle Prudhomme. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Planta Medica, Anti-Cancer Drugs and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.